InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated ...

InflaRx intends to engage with EMA regarding both vilobelimab and izicopan to evaluate the regulatory path to approval in ANCA-associated vasculitis (AAV)The Company is assessing the most efficient de ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By James Austin James Austin is a writer covering games and hobbies, which means ...

Training optimally, as the science suggests, isn't always realistic when you're balancing work, family and other commitments. But there are still plenty of ways to make your training work better for ...

Terms apply to American Express benefits and offers. Visit americanexpress.com to learn more. All payment methods involve some degree of risk, whether from human error, financial fraud or identity ...

Incyte (Nasdaq:INCY) today reports 2023 second quarter financial results, and provides a status update on the Company's clinical development portfolio. "We delivered ...

National security, unlocked. Each Thursday, host Mary Louise Kelly and a team of NPR correspondents discuss the biggest national security news of the week. With decades of reporting from battlefields ...

A major new study has found that mental health and behavioural changes such as depression, anxiety, and emotional instability are common in people who survive encephalitis — inflammation of the brain ...